Skip to main content

Month: January 2023

CenterPoint Energy, Inc. to Host Webcast of Fourth Quarter 2022 Earnings Conference Call

Houston, TX, Jan. 13, 2023 (GLOBE NEWSWIRE) —   Date:  February 17, 2023Time:  7:00 a.m. Central time or 8:00 a.m. Eastern timeListen via internet:  http://investors.centerpointenergy.com/Click “Investors”, and click the link “CenterPoint Energy, Inc. Fourth Quarter 2022 Earnings Conference Call”As the only investor-owned electric and gas utility based in Texas, CenterPoint Energy, Inc. (NYSE: CNP) ) is an energy delivery company with electric transmission and distribution, power generation and natural gas distribution operations that serve more than 7 million metered customers in Indiana, Louisiana, Minnesota, Mississippi, Ohio and Texas. As of September 30 2022, the company owned approximately $35 billion in assets. With approximately 8,900 employees, CenterPoint Energy and its predecessor...

Continue reading

Peyto Exploration & Development Corp. Confirms Monthly Dividend for February 15, 2023

CALGARY, Alberta, Jan. 13, 2023 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to January 2023 of $0.11 per common share is to be paid on February 15, 2023, for shareholders of record on January 31, 2023. The ex-dividend date for the January dividend is January 30, 2023. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes a monthly report, which discusses various topics chosen by the CEO and includes estimates of monthly capital expenditures and production. For further information...

Continue reading

Kimball International, Inc. to Announce Second Quarter Fiscal Year 2023 Financial Results

JASPER, Ind., Jan. 13, 2023 (GLOBE NEWSWIRE) — Kimball International, Inc. (NASDAQ: KBAL) will announce its second quarter fiscal year 2023 financial results on Thursday, February 2, 2023, after the close of the market. The Company will host a conference call on Thursday, February 2, 2023, at 5:00 p.m. ET to review its financial performance. To join the call, dial 1-833-535-2198 or internationally 1-412-317-0667 approximately ten minutes prior and tell the operator you wish to join Kimball International’s conference call.  The live webcast can be accessed at www.ir.kimballinternational.com. For those unable to participate in the live event, the call will be archived at www.ir.kimballinternational.com. About Kimball International, Inc. Kimball International is a leading omnichannel commercial furnishings company with deep expertise...

Continue reading

CFC To Host Conference Call on Fiscal Year 2023 Second-Quarter Financial Results

DULLES, Va., Jan. 13, 2023 (GLOBE NEWSWIRE) — The National Rural Utilities Cooperative Finance Corporation (CFC) will hold an investor conference call and webcast on Wednesday, January 18, at 11 a.m. Eastern Time. CFC CEO Andrew Don will provide a business update and CFC Senior Vice President and CFO Ling Wang will review CFC’s fiscal year 2023 second-quarter financial results. There are two ways to access the event:•   Live Webcast Option    Visit CFC’s investor Webcasts & Presentations page to join the webcast.    Pre-registration is available for the event.     •   Conference Call Option    Domestic: 888-394-8218 | International: 323-701-0225    Participant Code: 2903302    Callers also can view a PDF of the slide presentation by visiting the Webcasts & Presentations page on the day of the call....

Continue reading

United States Patent Office Allows Patent to Exosome Biomedical Company Nurexone

The patent covers Nurexone’s ExoPTEN drug compositions and treatment methods for Central Nervous System disease HAIFA, Israel and CALGARY, Alberta, Jan. 13, 2023 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (NRX:CVE) (J90:FRA) (the “Company” or “NurExone”), a biopharmaceutical company developing biologically-guided exosome therapy (“ExoTherapy”) for patients with traumatic spinal cord injuries, has received a notice of allowance from the United States Patent and Trademark Office (“USPTO”) for U.S. Patent Application NO. 17/042,441 (“the Patent”). The Patent covers and protects NurExone Exo-PTEN technology, and its drug composition as well as methods for non-invasive intranasal administration of exosome-based treatment. The Patent discloses and claims groundbreaking inventions and methods in exosome technology, such as the pharmaceutical...

Continue reading

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2022

Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2022 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Charenton-le-Pont, France (January 13, 2023 – 7:30 pm) – As of December 31, 2022, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.  December 31, 2022Shares outstanding           447,688,2331Number of real voting rights (excluding treasury shares) 445,327,583Theoretical number of voting rights (including treasury shares) 447,688,233It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with...

Continue reading

True Velocity to Display Next Gen Ammunition, Firearms at 2023 SHOT Show

GARLAND, Texas, Jan. 13, 2023 (GLOBE NEWSWIRE) —  Texas-based advanced defense technology company TV Ammo, Inc. (“True Velocity”), will be at booth #13454 from January 17 – 20 at SHOT Show 2023 hosted at the Venetian Expo and Caesars Forum in Las Vegas, Nevada. The appearance follows True Velocity’s recent announcement of a multi-year strategic partnership with industry-leading retailers Bass Pro Shops and Cabela’s. “We look forward every year to joining our industry colleagues at SHOT Show,” said Kevin Boscamp, Chairman and Co-CEO of True Velocity, “and this year is no different. We’re excited to show the world how True Velocity’s culture of innovation continues to result in disruptive, next-generation ammunition and weapons.” Products On Display:MILITARY AMMUNITION: 7.62x51mm NATO; 5.56x45mm NATO; .338, 50 BMG COMMERCIAL...

Continue reading

Nasdaq Halts Relativity Acquisition Corp.

NEW YORK, Jan. 13, 2023 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that the trading halt status in Relativity Acquisition Corp. (Nasdaq: RACY, RACYU and RACYW) was changed to “additional information requested” from the company. Trading in the company’s securities had been halted on January 11, 2023 at 17:14:36 Eastern Time for “news dissemination” at last sale prices of $12.28 (Nasdaq: RACY), $12.99 (Nasdaq: RACYU), $0.0471 (Nasdaq: RACYW). Trading will remain halted until Relativity Acquisition Corp.has fully satisfied Nasdaq’s request for additional information. For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site. For more information about The Nasdaq Stock Market, visit the...

Continue reading

Nasdaq Halts Arbor Rapha Capital Bioholdings Corp. I

NEW YORK, Jan. 13, 2023 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted on January 12, 2023 in Arbor Rapha Capital Bioholdings Corp. I (Nasdaq: ARCK, ARCKU and ARCKW) at 18:47:19. Eastern Time for “additional information requested” from the company at a last sale price of $11.90 (Nasdaq: ARCK), $12.00 (Nasdaq: ARCKU), $0.0966 (Nasdaq: ARCKW). Trading will remain halted until Arbor Rapha Capital Bioholdings Corp. I has fully satisfied Nasdaq’s request for additional information. For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site. For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq Media Contact: Sophia...

Continue reading

Ilkka Oyj – Acquisition of own shares on 13 January 2023

ILKKA OYJ, STOCK EXCHANGE RELEASE, 13 January 2023 at 19:00 EET Ilkka Oyj – Acquisition of own shares on 13 January 2023 At Nasdaq Helsinki Ltd:Date 13 January 2023Exchange transaction BuyShare trading code ILKKA2Amount, shares  1,176Average price/share, EUR 3.7867Total cost, EUR 4,453.16The company holds a total of 33,958 of its own shares (ILKKA2) including the shares acquired on 13 January 2023. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Ilkka Oyj DANSKE BANK A/S, FINLAND BRANCH Jonathan Nyberg        Antti Väliaho Additional information Olli Pirhonen, CEO, Ilkka Oyj, tel. +358 40 766 5418 www.ilkka.comAttachmentIlkka buyback 13.1.2023

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.